View in EDS HTML Full Text PDF Full Text

Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors.

Saved in:
Bibliographic Details
Title: Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors.
Authors: Herrgott GA; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Department of Neurosurgery, Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA., Asmaro KP; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Department of Neurosurgery, Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA., Wells M; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Department of Neurosurgery, Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA., Sabedot TS; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Department of Neurosurgery, Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA., Malta TM; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Department of Neurosurgery, Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA., Mosella MS; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Department of Neurosurgery, Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA., Nelson K; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Scarpace L; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Barnholtz-Sloan JS; Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA., Sloan AE; Department of Neurological Surgery, University Hospitals of Cleveland, Cleveland, Ohio, USA.; Case Comprehensive Cancer Center, Cleveland, Ohio, USA., Selman WR; Department of Neurological Surgery, University Hospitals of Cleveland, Cleveland, Ohio, USA., deCarvalho AC; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Poisson LM; Department of Biostatistics, Henry Ford Health System, Detroit, Michigan, USA., Mukherjee A; Department of Pathology, Henry Ford Health System, Detroit, Michigan, USA., Robin AM; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Lee IY; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Snyder J; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Department of Neurosurgery, Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA., Walbert T; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Rosenblum M; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Mikkelsen T; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Bhan A; Department of Endocrinology, Henry Ford Health System, Detroit, Michigan, USA., Craig J; Department of Otolaryngology, Skull Base, Pituitary and Endoscopy Center, Henry Ford Health System, Detroit, Michigan, USA., Kalkanis S; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Rock J; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA., Noushmehr H; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Department of Neurosurgery, Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA., Castro AV; Department of Neurosurgery, Hermelin Brain Tumor Center, Henry Ford Health System, Detroit, Michigan, USA.; Department of Neurosurgery, Omics Laboratory, Henry Ford Health System, Detroit, Michigan, USA.
Source: Neuro-oncology [Neuro Oncol] 2022 Jul 01; Vol. 24 (7), pp. 1126-1139.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1523-5866
DOI:10.1093/neuonc/noac050